Skip to main content

Table 1 Respondent characteristics among general practitioners randomised to six versions (A-F)a of a vignette portraying a patient with an unfavourable cardiovascular risk profile

From: Decisions on statin therapy by patients’ opinions about survival gains: cross sectional survey of general practitioners

Group

Mean age

Proportion female

Mean # of patients listed

Specialty attainment

A

47

84/236 (36 %)

1222

149/237 (63 %)

B

48

77/211 (37 %)

1188

150/214 (70 %)

C

47

64/203 (32 %)

1242

138/203 (68 %)

D

48

85/225 (38 %)

1216

156/226 (69 %)

E

47

81/220 (37 %)

1175

139/220 (63 %)

F

47

78/208 (38 %)

1213

130/208 (63 %)

All Norwegian GPs n = 4,049b

49c

35%c

1182c

55%d

  1. aThe vignettes differed with respect to the survival gain the patient would require to consider simvastatin therapy worthwhile (A: 3 months, B: 6 months, C: 12 months, D: 2 years, E: 4 years, F: 8 years)
  2. bStatistics Norway (http://www.ssb.no accessed 24th of March 2011)
  3. c https://helsedirektoratet.no/Documents/Statistikk%20og%20analyse/Fastlegestatistikk/Fastlegestatistikk%20hovedtallsrapport-2010.pdf
  4. dhttp://www.legeforeningen.no/id/18 14.04.2011